Table 3.
CYP2C19 681 genotypes of the patients in the survival group and the death group stratified by smoking history
| Smoking history | Prognosis | Total (n) | Genotypesa | P valueb | P valuec | ||
|---|---|---|---|---|---|---|---|
| GG (n) | GA (n) | AA (n) | |||||
| Current smoking | Survival | 218 | 98 | 85 | 35 | 0.815 | 0.619 |
| Death | 117 | 50 | 46 | 21 | |||
| Former smoking | Survival | 64 | 42 | 18 | 4 | 0.168 | 0.020 |
| Death | 42 | 19 | 15 | 8 | |||
| Non‐smoking | Survival | 132 | 70 | 51 | 11 | 0.285 | 0.000 |
| Death | 27 | 8 | 10 | 9 | |||
a
GG: CYP2C19 681 wild‐type homozygotes, GA: CYP2C19 681 mutant heterozygotes, AA: CYP2C19 681 mutant homozygotes.
b
GG group versus GA group.
c
GG group versus AA group.